1-5 of 5
Authors: Rodolphe Thiebaut
Journal Article
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 10, October 2017, Pages 2869–2878, https://doi.org/10.1093/jac/dkx210
Published: 17 July 2017
Journal Article
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 5, May 2016, Pages 1352–1360, https://doi.org/10.1093/jac/dkv465
Published: 28 January 2016
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells Get access
Journal of Antimicrobial Chemotherapy, Volume 65, Issue 3, March 2010, Pages 434–437, https://doi.org/10.1093/jac/dkp473
Published: 05 January 2010
Journal Article
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort Get access
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 6, June 2009, Pages 1251–1255, https://doi.org/10.1093/jac/dkp114
Published: 31 March 2009
